Literature DB >> 25178752

Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome.

Nadine Revheim, Cheryl M Corcoran, Elisa Dias, Esther Hellmann, Antigona Martinez, Pamela D Butler, Jonathan M Lehrfeld, Joanna DiCostanzo, Jennifer Albert, Daniel C Javitt.   

Abstract

OBJECTIVE: The ability to read passages of information fluently and with comprehension is a basic component of socioeconomic success. Reading ability depends on the integrity of underlying visual and auditory (phonological) systems. This study investigated the integrity of reading ability in schizophrenia relative to the integrity of underlying visual and auditory function.
METHOD: The participants were 45 schizophrenia patients, 19 clinical high-risk patients, and 65 comparison subjects. Reading was assessed using tests sensitive to visual or phonological reading dysfunction. Sensory, neuropsychological, and functional outcome measures were also obtained.
RESULTS: Schizophrenia patients displayed reading deficits that were far more severe (effect size >2.0) than would be predicted based on general neurocognitive impairments (effect size 1.0-1.4). The deficits correlated highly with both visual and auditory sensory measures, including impaired mismatch negativity generation (r=0.62, N=51, p=0.0002). Patients with established schizophrenia displayed both visual and phonological impairments, whereas high-risk patients showed isolated visual impairments. More than 70% of schizophrenia patients met criteria for acquired dyslexia, with 50% reading below eighth grade level despite intact premorbid reading ability. Reading deficits also correlated significantly (rp=0.4, N=30, p=0.03) with failure to match parental socioeconomic achievement, over and above contributions of more general cognitive impairment.
CONCLUSIONS: Patients with schizophrenia display severe deficits in reading ability that represent a potentially remediable cause of impaired socioeconomic function. Such deficits are not presently captured during routine clinical assessment. Deficits most likely develop during the years immediately surrounding illness onset and may contribute to the reduced educational and occupational achievement associated with schizophrenia.

Entities:  

Mesh:

Year:  2014        PMID: 25178752      PMCID: PMC4501394          DOI: 10.1176/appi.ajp.2014.13091196

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  44 in total

1.  Impaired auditory frequency discrimination in dyslexia detected with mismatch evoked potentials.

Authors:  T Baldeweg; A Richardson; S Watkins; C Foale; J Gruzelier
Journal:  Ann Neurol       Date:  1999-04       Impact factor: 10.422

Review 2.  Neural underpinnings of dyslexia as a disorder of visuo-spatial attention.

Authors:  Trichur R Vidyasagar
Journal:  Clin Exp Optom       Date:  2004-01       Impact factor: 2.742

3.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

4.  Naming-speed processes and developmental reading disabilities: an introduction to the special issue on the double-deficit hypothesis.

Authors:  M Wolf; P G Bowers
Journal:  J Learn Disabil       Date:  2000 Jul-Aug

5.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

6.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

7.  Early-stage visual processing and cortical amplification deficits in schizophrenia.

Authors:  Pamela D Butler; Vance Zemon; Isaac Schechter; Alice M Saperstein; Matthew J Hoptman; Kelvin O Lim; Nadine Revheim; Gail Silipo; Daniel C Javitt
Journal:  Arch Gen Psychiatry       Date:  2005-05

8.  Socioeconomic status and psychiatric disorders: the causation-selection issue.

Authors:  B P Dohrenwend; I Levav; P E Shrout; S Schwartz; G Naveh; B G Link; A E Skodol; A Stueve
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

9.  Auditory sensory ("echoic") memory dysfunction in schizophrenia.

Authors:  R D Strous; N Cowan; W Ritter; D C Javitt
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

10.  Preserved reading and spelling ability in psychotic disorders.

Authors:  J T Dalby; R Williams
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

View more
  37 in total

Review 1.  Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.

Authors:  Daniel C Javitt
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

2.  Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Barbara A Cornblatt; Danielle McLaughlin; Jeremy Chang; Andrea M Auther; Ruth H Olsen; Daniel C Javitt
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

3.  Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

Authors:  C M Corcoran; J G Keilp; J Kayser; C Klim; P D Butler; G E Bruder; R C Gur; D C Javitt
Journal:  Psychol Med       Date:  2015-06-04       Impact factor: 7.723

4.  The effect of bilateral transcranial direct current stimulation on early auditory processing in schizophrenia: a preliminary study.

Authors:  Walter Dunn; Yuri Rassovsky; Jonathan Wynn; Allan D Wu; Marco Iacoboni; Gerhard Hellemann; Michael F Green
Journal:  J Neural Transm (Vienna)       Date:  2017-07-07       Impact factor: 3.575

5.  Contrast sensitivity and motion discrimination in cannabis users.

Authors:  Elena Mikulskaya; Frances Heritage Martin
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

Review 6.  Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.

Authors:  Jennifer K Forsyth; David A Lewis
Journal:  Trends Cogn Sci       Date:  2017-07-25       Impact factor: 20.229

7.  Neurophysiological, Oculomotor, and Computational Modeling of Impaired Reading Ability in Schizophrenia.

Authors:  Elisa C Dias; Heather Sheridan; Antígona Martínez; Pejman Sehatpour; Gail Silipo; Stephanie Rohrig; Ayelet Hochman; Pamela D Butler; Matthew J Hoptman; Nadine Revheim; Daniel C Javitt
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

8.  Consistent Functional Connectivity Alterations in Schizophrenia Spectrum Disorder: A Multisite Study.

Authors:  Kristina C Skåtun; Tobias Kaufmann; Nhat Trung Doan; Dag Alnæs; Aldo Córdova-Palomera; Erik G Jönsson; Helena Fatouros-Bergman; Lena Flyckt; Ingrid Melle; Ole A Andreassen; Ingrid Agartz; Lars T Westlye
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 9.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

10.  Patients with first-episode untreated schizophrenia who experience concomitant visual disturbances and auditory hallucinations exhibit co-impairment of the brain and retinas-a pilot study.

Authors:  Chuanjun Zhuo; Bo Xiao; Feng Ji; Xiaodong Lin; Deguo Jiang; Hongjun Tian; Yong Xu; Wenqiang Wang; Ce Chen
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.